32.81
+1.64(+5.26%)
Currency In USD
Address
681 Gateway Boulevard
South San Francisco, CA 94080
United States of America
Phone
800 719 0671
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
923
First IPO Date
October 31, 2018
| Name | Title | Pay | Year Born |
| Dr. Emily Marine Leproust Ph.D. | Co-Founder, Board Chair & Chief Executive Officer | 1.77M | 1973 |
| Ms. Paula Green | Senior Vice President of Human Resources | 776,221 | 1968 |
| Mr. Dennis Cho J.D. | Senior Vice President, Chief Legal Officer & Corporate Secretary | 776,519 | 1971 |
| Mr. Adam Laponis | Chief Financial Officer | 810,644 | 1977 |
| Dr. Patrick John Finn Ph.D. | President & Chief Operating Officer | 1.09M | 1972 |
| Mr. Robert F. Werner | Vice President & Chief Accounting Officer | 0 | 1973 |
| Mr. Siyuan Chen | Chief Technology Officer | 0 | N/A |
| Ms. Angela Bitting | Chief Corporate Responsibility Officer & Senior Vice President of Corporate Affairs | 0 | N/A |
| Dr. Michael Fero Ph.D. | Chief Information Officer | 0 | N/A |
| Ms. Nicole Moreno | Senior Vice President of Sales & Support | 0 | N/A |
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California.